Health problems among detainees in Switzerland: a study using the ICPC-2 classification

Wolff, Hans; Sebo, Paul; Haller, Dagmar M.; Eytan, Ariel; Niveau, Gérard; Bertrand, Dominique; Gétaz, Laurent; Cerutti, Bernard

doi:10.1186/1471-2458-11-245

Cited by 40 publications

(57 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Further studies have also examined the disease burden of prisoners comparing the results among prisoners of different age groups [22,23,24,25,26], concluding that multiple morbidity is high among prisoners, with mental illnesses, infectious diseases and drug abuse as common health problems [15,27,28]. Aday [29] and Deaton et al [30] pointed out that older prisoners report suffering from 3-4 chronic conditions.…”

Section: Introductionmentioning

confidence: 99%

Ageing Prisoners' Disease Burden: Is Being Old a Better Predictor than Time Served in Prison?

Wangmo¹,

Meyer

Handtke³

et al. 2014

Gerontology

View full text Add to dashboard Cite

Background: The number of older prisoners entering and ageing in prison has increased in the last few decades. Ageing prisoners pose unique challenges to the prison administration as they have differentiated social, custodial and healthcare needs than prisoners who are younger and relatively healthier. Objective: The goal of this study was to explore and compare the somatic disease burden of old and young prisoners, and to examine whether it can be explained by age group and/or time served in prison. Methods: Access to prisoner medical records was granted to extract disease and demographic information of older (>50 years) and younger (≤49 years) prisoners in different Swiss prisons. Predictor variables included the age group and the time spent in prison. The dependent variable was the total number of somatic diseases as reported in the medical records. Results were analysed using descriptive statistics and a negative binomial model. Results: Data of 380 male prisoners from 13 different prisons in Switzerland reveal that the mean ages of older and younger prisoners were 58.78 and 34.26 years, respectively. On average, older prisoners have lived in prison for 5.17 years and younger prisoners for 2.49 years. The average total number of somatic diseases reported by older prisoners was 2.26 times higher than that of prisoners below 50 years of age (95% CI 1.77-2.87, p < 0.001). Conclusion: This study is the first of its kind to capture national disease data of prisoners with a goal of comparing the disease burden of older and younger prisoners. Study findings indicate that older inmates suffer from more somatic diseases and that the number of diseases increases with age group. Results clearly illustrate the poorer health conditions of those who are older, their higher healthcare burden, and raises questions related to the provision of healthcare for inmates growing old in prison.

show abstract

Section: Introductionmentioning

confidence: 99%

Ageing Prisoners' Disease Burden: Is Being Old a Better Predictor than Time Served in Prison?

Wangmo¹,

Meyer

Handtke³

et al. 2014

Gerontology

View full text Add to dashboard Cite

show abstract

“…The existence and direction of non-response bias is difficult to estimate (Etter and Perneger, 1997). Nevertheless, our sample of prisoners was not atypical (high smoking prevalence, high proportion of foreigners with no residence permit) (Wolff et al, 2011).…”

Section: Strengths and Limitationsmentioning

confidence: 99%

Implementation and impact of anti-smoking interventions in three prisons in the absence of appropriate legislation

Etter

Ritter

Christie

et al. 2012

Preventive Medicine

Self Cite

View full text Add to dashboard Cite

“…[3] In Switzerland, the HCV antibody prevalence is 0.71% amongst the general population, [4] and the prevalence of HCV among PLD ranges between 5.7% and 6.2%. [5,6] This is due to the large proportion of high risk groups such as people who inject drugs (PWID), and those from countries where HCV is endemic. [7,8] In the canton of Geneva, which has a population of 381,000 over the age of 18, 1,789 adults are incarcerated each year, [9,10] and it is estimated that 4.1% of these are infected with HCV.…”

Section: Introductionmentioning

confidence: 99%

Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting

Girardin

Hearmon

Castro

et al. 2019

Clinical Infectious Diseases

Self Cite

View full text Add to dashboard Cite

Background Hepatitis C virus (HCV) among people living in detention (PLD) is typically high in many countries including Switzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%. In Switzerland, the existing screening strategy involves routine screening of PLD who indicate they are from HCV high-risk populations based on questionnaire responses upon entry to the detention center, rather than an offer to screen all PLD. Methods A cost-effectiveness analysis from a Swiss healthcare provider perspective was conducted by combining a 5-year decision tree screening model with results from a Markov model of HCV treatment outcomes. This model explored the cost-effectiveness of increased HCV screening to cover all PLD compared to the current approach, using a standard test package and subsequent treatment with a single-tablet regimen in Swiss custodial settings. Sensitivity and scenario analyses examined the uncertainty of results. Results At the willingness-to-pay threshold of 100 000 Swiss Francs (CHF) per quality-adjusted life-year (QALY), comprehensive general screening was cost-effective compared to current risk-based screening, with a base case incremental cost-effectiveness ratio of CHF 14 312 per QALY. The net monetary benefit of screening the whole PLD population was CHF 23 298 046 and CHF 4298 per person. The proportion of PLD tested was predicted to increase from 13.6% to 67.0% under comprehensive screening. Conclusion The results showed that comprehensive screening strategies in detention centers in Switzerland can be cost-effective, with the probabilistic sensitivity analysis estimating an 82.3% probability of cost-effectiveness.

show abstract

Health problems among detainees in Switzerland: a study using the ICPC-2 classification

Cited by 40 publications

References 26 publications

Ageing Prisoners' Disease Burden: Is Being Old a Better Predictor than Time Served in Prison?

Ageing Prisoners' Disease Burden: Is Being Old a Better Predictor than Time Served in Prison?

Implementation and impact of anti-smoking interventions in three prisons in the absence of appropriate legislation

Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting

Contact Info

Product

Resources

About